How Does Johnson & Johnson’s Revenue And Other Key Metrics Compare With That of Roche?Forbes • 12/26/19
J&J to buy remaining stake in Verb Surgical to strengthen digital surgery portfolioReuters • 12/20/19
One options trader just made a $2 million bet on Johnson & Johnson. Here's why it could work outCNBC • 12/18/19
J&J's CAR-T Therapy Targeting BCMA Proves Itself In Treating Highly Refractory Multiple Myeloma PatientsSeeking Alpha • 12/17/19
Johnson & Johnson's CAR-T Therapy Targeting BCMA Proves Itself In Treating Highly Refractory Multiple Myeloma PatientsSeeking Alpha • 12/17/19
Can Johnson & Johnson’s Imbruvica Sales Beat Roche’s Rituxan In Chronic Lymphocytic Leukemia Market By 2021?Forbes • 12/09/19